APC-Linked Anti-Epidermal Growth Factor Receptor (EGFR) Polyclonal Antibody    
    
ErbB-1; ErbB1; ER1; ERB-B1; MENA; HER1; Erythroblastic Leukemia Viral(v-Erb-B)oncogene Homolog,Avian; Proto-oncogene c-ErbB-1; Receptor tyrosine-protein kinase erbB-1
- UOM
 - FOB US$ 240.00 US$ 400.00 US$ 640.00 US$ 800.00 US$ 1,400.00
 - Quantity
 
Overview
Properties
- Product No.FAA757Hu51
 - Organism SpeciesHomo sapiens (Human) Same name, Different species.
 - ApplicationsFCM
Research use only - Downloadn/a
 - CategoryCD & Adhesion moleculeTumor immunity
 
- Ig Type IgG, Potency n/a
 - PurificationAntigen-specific affinity chromatography followed by Protein A affinity chromatography
 - LabelAPC
 - Excitation Laser
 - Vol. per test
 - Buffer Formulation10mM tris, 150mM NaCl, pH8.2, containing 0.05% Proclin-300.
 - TraitsLiquid
 
    Share your citation
    Upload your experimental result
    Review
    Leave a message
    
        
    
        
        
    
        
        
            
                
                
            
            
                
                
            
            
                
                
            
            
            
                
            
        
    
    
         
        
            
                
                
            
            
                
                
                
            
            
            
                
            
        
    
    
         
        
            
                
                
                
                
            
            
                
            
            
                
            
        
      
    
         
        
            
                
            
        
    
                    
        Loading...
        
    Sign into your account
Share a new citation as an author
Upload your experimental result
Review
                
                 Please attach serial No. on instruction manual
                
            
            
            
Contact us
Please fill in the blank.
                Name*
                
            
            
                Organization
                
            
            
                Address
                
            
            
                E-mail address*
                
            
            
                Telephone
                
            
            
                Inquiry*
                
            
            
                Verification code*
                
                
            
            
            Usage
                            For flow cytometry, the suggested use of this reagent is 0.5-2 µl per 10^6 cells in 100 µl volume.
Optimal working dilutions must be determined by end user.                        
Storage
Store at 4°C, protected from prolonged exposure to light.
Giveaways
Increment services
- 
                
                    Protein A/G Purification Column
                                 - 
                
                    Positive Control  for Antibody
                                 - 
                
                    Tissue/Sections Customized Service
                                 - 
                
                    Phosphorylated Antibody Customized Service
                                 - 
                
                    Flow Cytometry (FCM) Experiment Service
                                 - 
                
                    Immunoprecipitation (IP) Experiment Service
                                 - 
                
                    Immunofluorescence (IF) Experiment Service
                                 - 
                
                    Buffer
                                 - 
                
                    DAB Chromogen Kit
                                 - 
                
                    SABC Kit
                                 - 
                
                    Isotype Control
                                 - 
                
                    Real Time PCR Experimental Service
                                 
Citations
- Nimotuzumab combined with gemcitabine and cisplatin as second-line chemotherapy for advanced non-small-cell lung cancerWiley: source
 - Increased Epidermal Growth Factor Receptor (EGFR) Associated with Hepatocyte Growth Factor (HGF) and Symptom Severity in Children with Autism …Pubmed:25249767
 - GC1118, an anti-EGFR antibody with a distinct binding epitope and superior inhibitory activity against high-affinity EGFR ligandsPubMed: 26586721
 - LINC01225 promotes occurrence and metastasis of hepatocellular carcinoma in an epidermal growth factor receptor-dependent pathwayPubmed:26938303
 - Microfluidic immunosensor based on mesoporous silica platform and CMK-3/poly-acrylamide-co-methacrylate of dihydrolipoic acid modified gold electrode for cancer biomarker detection.pubmed:28335979
 - EGFR detection in extracellular vesicles of breast cancer patients through immunosensor based on silica-chitosan nanoplatformDoi: 10.1016/j.talanta.2018.10.016
 - Design, synthesis, molecular docking and biological activity evaluation of some novel indole derivatives as potent anticancer active agents and apoptosis inducersPubmed: 30665034
 - Novel thienopyrimidine derivatives as dual EGFR and VEGFR-2 inhibitors: design, synthesis, anticancer activity and effect on cell cycle profilePubmed: 30919701
 - Design and synthesis of new benzoxazole/benzothiazole-phthalimide hybrids as antitumor-apoptotic agents
 - Synthesis and anticancer activity of bis-benzo [d][1, 3] dioxol-5-yl thiourea derivatives with molecular docking studyPubmed: 31288134
 - Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters …Pubmed: 31737175
 - Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicinePubmed: 33212364
 - Association between Serum Epidermal Growth Factor Receptor and Cyclooxygenase-2 Levels in Patients with Non-small Cell Carcinoma of Lung
 - Synthesis, EGFR-TK inhibition and anticancer activity of new quinoxaline derivatives
 - Humoral immune response to epidermal growth factor receptor in lung cancer33495907
 - Pyrazolo[3,4-d]pyrimidine-based dual EGFR T790M/HER2 inhibitors: Design, synthesis, structure¨Cactivity relationship and biological activity as potential antitumor and anticonvulsant agents33545637
 - Design, synthesis, antiproliferative evaluation, and molecular docking study of new quinoxaline derivatives as apoptotic inducers and EGFR inhibitors
 - Emitter–Quencher Pair of Single Atomic Co Sites and Monolayer Titanium Carbide MXenes for Luminol Chemiluminescent Reactions34914377
 - Discovery of new pyrimido [5, 4-c] quinolines as potential antiproliferative agents with multitarget actions: Rapid synthesis, docking, and ADME studiesPubmed:35219045
 
